AICDA and cryopyrin-associated periodic syndrome: NLRP3-AID, formerly termed cryopyrin-associated periodic syndrome (CAPS), comprises a group of disorders arising from monoallelic, gain-of-function mutations in the NLRP3 (CIAS1) gene, which induce neutrophil-mediated inflammation [15].